chr11-101958328-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_020802.4(CEP126):c.667C>G(p.Gln223Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,820 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020802.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152180Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251040Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135704
GnomAD4 exome AF: 0.0000732 AC: 107AN: 1461640Hom.: 2 Cov.: 31 AF XY: 0.0000990 AC XY: 72AN XY: 727108
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152180Hom.: 1 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.667C>G (p.Q223E) alteration is located in exon 5 (coding exon 5) of the CEP126 gene. This alteration results from a C to G substitution at nucleotide position 667, causing the glutamine (Q) at amino acid position 223 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at